Home
Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.
Upcoming as of 2026-11-19 , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.
8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.
Add to your calendar (calendar.ics)
The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.
Upcoming
December 2028 250
2028-12-31
2028-12-31
Primary completion Head Cooling in Ischaemic Stroke Patients Undergoing Endovascular Thrombectomy (COOLHEAD-2b) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07526649
2028-12-31
2028-12-31
2028-12-31
2028-12-31
2028-12-31
2028-12-31
2028-12-31
2028-12-31
Study completion GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07613437
2028-12-31
Study completion SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07614230
2028-12-31
2028-12-31
Primary completion In-Hospital Wearable-Based Monitoring Versus Standard Care in Cardiovascular Disease (INSPIRE) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07622485
2028-12-31
Study completion fNIRS for Monitoring Cortical Activity in Stroke Recovery Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07623512
2028-12-31
Primary completion fNIRS for Monitoring Cortical Activity in Stroke Recovery Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07623512
2028-12-31
2028-12-31
2028-12-31
Study completion Randomized Study of Triple Therapy vs Sildenafil Dose Optimization in Pulmonary Arterial Hypertension Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07713914
2028-12-31
Study completion Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07719894
2028-12-31
Primary completion Digital Long-term Follow-up of Patients With Coronary Artery Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07720349
2028-12-31
Study completion INtra-arterial AltEplase folloWing successfuL reperfusIoN After mEchanical Thrombectomy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07727395
2028-12-31
Primary completion INtra-arterial AltEplase folloWing successfuL reperfusIoN After mEchanical Thrombectomy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07727395
2028-12-31
Study completion Tirofiban Combined With Aspirin in Moderate Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07760922
2028-12-31
Primary completion Tirofiban Combined With Aspirin in Moderate Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07760922
2028-12-31
Primary completion Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07762755
2028-12-31
Study completion Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07763405
2028-12-31
Primary completion Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07763405
2028-12-31
2028-12-31
2028-12-31
Primary completion Unimanual Versus Bimanual Motor Skill Learning in Acute and Chronic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07826832
2028-12-31
2028-12-31
Study completion Combined Acupuncture-Based Therapy for Rehabilitation After Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07846488
2028-12-31
2028-12-31
Study completion Sitogilun Malate Plus Amlodipine in Patients With Hypertension and Risk of Early Kidney Damage Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07876544
2028-12-31
Primary completion Sitogilun Malate Plus Amlodipine in Patients With Hypertension and Risk of Early Kidney Damage Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07876544
2028-12-31
Primary completion Reduced-Dose Thrombolysis in Intermediate-Risk Pulmonary Embolism With High-Risk Features Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07917078
January 2029 46
2029-01-01
Primary completion Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05700877
2029-01-01
Primary completion Beta-blockade in Unruptured Intracranial Aneurysm Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06249802
2029-01-01
Primary completion Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06468202
2029-01-01
Primary completion Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06725810
2029-01-01
2029-01-01
Primary completion STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07644247
2029-01-01
Primary completion RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07819643
2029-01-01
Study completion Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07858331
2029-01-01
Primary completion Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07858331
2029-01
Primary completion Avoiding Anticoagulation After IntraCerebral Haemorrhage Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03243175
2029-01
Primary completion Amplatzer Amulet LAAO vs. NOAC Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04226547
2029-01
Study completion POHCA Resuscitation: Evaluation of IM Epinephrine Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05166343
2029-01
2029-01
Primary completion Methylprednisolone With Endovascular Thrombectomy for Large Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06870448
2029-01
2029-01
Primary completion Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07227246
2029-01
2029-01
Study completion Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07434661
2029-01
Study completion Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07658807
2029-01
Study completion ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms. Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07737964
2029-01
Primary completion ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms. Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07737964
2029-01
2029-01
Study completion MUTTON-HF Pilot Expansion Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07922863
2029-01-06
Study completion Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07189234
2029-01-15
Study completion Dapagliflozin for Cardio-renal Protection After ICU Discharge Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07025629
2029-01-15
Primary completion Dapagliflozin for Cardio-renal Protection After ICU Discharge Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07025629
2029-01-15
2029-01-19
2029-01-28
2029-01-28
Primary completion A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07816185
2029-01-30
Primary completion DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07322237
2029-01-30
2029-01-31
Study completion 2019-06 TRISCEND Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04221490
2029-01-31
2029-01-31
Primary completion StrokeNet Thrombectomy Endovascular Platform Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06289985
2029-01-31
2029-01-31
2029-01-31
2029-01-31
2029-01-31
Study completion Efficacy and Safety of Micra AV2 Transcatheter Pacing System Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07356505
2029-01-31
Study completion Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07444372
2029-01-31
Primary completion Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07444372
2029-01-31
Study completion Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07511543
2029-01-31
Primary completion Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07668323
2029-01-31
Primary completion APEX-STROKE CALM-ICH Domain Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07752719
2029-01-31
February 2029 40
2029-02-01
Study completion Assessment of CCM in HF With Higher Ejection Fraction Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05064709
2029-02-01
Primary completion Assessment of CCM in HF With Higher Ejection Fraction Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05064709
2029-02-01
2029-02-01
Study completion Physiology of Unloading VA ECMO Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06336655
2029-02-01
Study completion Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06725810
2029-02-01
2029-02-01
Primary completion HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07379190
2029-02-01
Study completion Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07846579
2029-02
2029-02
2029-02
2029-02
Primary completion CGM for Management of Type 2 Diabetes in Pregnancy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06628453
2029-02
Study completion ELEVATE-HFpEF Clinical Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06678841
2029-02
Primary completion Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06777901
2029-02
Study completion Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07083765
2029-02
2029-02
Study completion HEARTS in Sync + CardioWatch 287-2 Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07322510
2029-02-02
Study completion CLEANer Aspiration for Pulmonary Embolism Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06189313
Overdue
The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.
2025-01
Primary completion DIAbetes Maximal ACCeleration Registry record
Expected 2025-01; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05646147
2025-01-31
Study completion Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response Registry record
Expected 2025-01-31; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05691959
2025-01-31
Primary completion Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response Registry record
Expected 2025-01-31; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05691959
2025-01
2025-01
Primary completion METFORMIN FOR ATRIAL FIBRILLATION Registry record
Expected 2025-01; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05878535
2025-01
Primary completion A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE) Registry record
Expected 2025-01; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05961787
2025-01-31
Primary completion CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke Registry record
Expected 2025-01-31; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06078215
2025-01
Study completion EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE) Registry record
Expected 2025-01; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06138834
2025-01
Primary completion Effects of Levosimendan on Cardiac Function After TAVR in Patients With Heart Failure Registry record
Expected 2025-01; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06196177
2025-01-31
Study completion Impact of Sleep Quality on Outcomes After Cardiac Surgery Registry record
Expected 2025-01-31; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06527105
2025-01-31
Study start Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure Registry record
Expected 2025-01-31; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06669169
2025-01
Study start Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection Fraction Registry record
Expected 2025-01; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06712030
2025-01
Study start Low-dose Evaluation of Aspirin After STEMI Patients With PCI: A Multicenter, Double-blind, Randomized Controlled Clinical Trial Registry record
Expected 2025-01; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06756945
2025-01
2025-02-01
Study completion Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions Registry record
Expected 2025-02-01; that period ended on 2025-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05209412
2025-02-01
Primary completion Future Patient - Telerehabilitation of Patients With Atrial Fibrillation Registry record
Expected 2025-02-01; that period ended on 2025-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06101485
2025-02-01
Study completion Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During Hospitalization Registry record
Expected 2025-02-01; that period ended on 2025-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06102720
2025-02-01
Study start Oral Bedtime Melatonin in Critically Ill Patients Registry record
Expected 2025-02-01; that period ended on 2025-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06156059
2025-02-01
Primary completion Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-B ) Registry record
Expected 2025-02-01; that period ended on 2025-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06492265
2025-02-01
Primary completion Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices Registry record
Expected 2025-02-01; that period ended on 2025-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06652750
2025-02-01
Study start StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial Registry record
Expected 2025-02-01; that period ended on 2025-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06785727
2025-02-01
Study start Adjuvant Cerebroprotection Using Normobaric Hyperoxia in Pre-hospital Patients with Suspected Stroke Registry record
Expected 2025-02-01; that period ended on 2025-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06801457
2025-02-02
Study completion Brain Connectivity Measured With High-density Electroencephalography Registry record
Expected 2025-02-02; that period ended on 2025-02-02.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06298097
2025-02-02
Primary completion Brain Connectivity Measured With High-density Electroencephalography Registry record
Expected 2025-02-02; that period ended on 2025-02-02.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06298097
2025-02-03
Study completion Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients Registry record
Expected 2025-02-03; that period ended on 2025-02-03.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06717685
2025-02-10
Primary completion Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins Registry record
Expected 2025-02-10; that period ended on 2025-02-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06262685
2025-02-15
Study completion OCT Guided Magmaris RMS in STEMI Registry record
Expected 2025-02-15; that period ended on 2025-02-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03955731
2025-02-15
Primary completion OCT Guided Magmaris RMS in STEMI Registry record
Expected 2025-02-15; that period ended on 2025-02-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03955731
2025-02-15
Study start Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation Registry record
Expected 2025-02-15; that period ended on 2025-02-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06791629
2025-02-18
Study completion The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis Registry record
Expected 2025-02-18; that period ended on 2025-02-18.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04733443
2025-02-18
Study completion Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with CKD Registry record
Expected 2025-02-18; that period ended on 2025-02-18.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05359263
2025-02-18
Primary completion Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with CKD Registry record
Expected 2025-02-18; that period ended on 2025-02-18.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05359263
2025-02-22
Primary completion GD-11 for Injection in the Treatment of Acute Ischemic Stroke Registry record
Expected 2025-02-22; that period ended on 2025-02-22.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06299579
2025-02
Study completion Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02661451
2025-02
Study completion Hemodialysis in the Elderly (70yrs & Older) Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03065972
2025-02
Primary completion Hemodialysis in the Elderly (70yrs & Older) Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03065972
2025-02-28
Study completion PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia Registry record
Expected 2025-02-28; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03970538
2025-02-28
Study completion Ankle Robotics After Stroke Registry record
Expected 2025-02-28; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04594837
2025-02-28
Primary completion Ankle Robotics After Stroke Registry record
Expected 2025-02-28; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04594837
2025-02
Study completion Early Detection of Atrial Fibrillation Using Mobile Technology in Cryptogenic Stroke Patients Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05006105
2025-02
Primary completion Early Detection of Atrial Fibrillation Using Mobile Technology in Cryptogenic Stroke Patients Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05006105
2025-02
Study completion Clinical Impact of the IBox As an Early Intervention TooL Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05112315
2025-02
Primary completion Clinical Impact of the IBox As an Early Intervention TooL Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05112315
2025-02-28
Study completion Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk Registry record
Expected 2025-02-28; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05240781
2025-02
Study completion Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05431296
2025-02
Primary completion Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05487261
2025-02
Study completion Safety and Effectiveness of Left Bundle Branch Pacing in Patients With Cardiac Dysfunction and AV Block Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05553626
2025-02
Study completion Clinical Study of Focal Implant Used for Lower Extremity Post-angioplasty Dissection Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05562076
2025-02-28
Study completion Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window Registry record
Expected 2025-02-28; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05634382
2025-02-28
Study completion DCB Under the Guidance of OCT in STEMI Registry record
Expected 2025-02-28; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05680051
2025-02-28
Primary completion Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) Registry record
Expected 2025-02-28; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05887817
2025-02
Study completion Effects of Levosimendan on Cardiac Function After TAVR in Patients With Heart Failure Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06196177
2025-02
Study completion MCG for Localization of Tachyarrhythmia's Origin Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06327425
2025-02
Study completion Phase III Study to Evaluate the Efficacy and Safety of AD-209 Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06348576
2025-02
Primary completion Phase III Study to Evaluate the Efficacy and Safety of AD-209 Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06348576
2025-02-28
Study completion The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes Registry record
Expected 2025-02-28; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06408532
2025-02-28
Primary completion Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions Registry record
Expected 2025-02-28; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06441539
2025-02
Primary completion The Effect of Probiotics vs Activated Charcoal in the Management of CKD Patients Suffering From Uremic Pruritus. Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06579066
2025-02
Primary completion Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06616961
2025-02-28
Primary completion Remote Multichannel Monitoring of Patients With Chronic DIseAses Using Speech technoLogies Based On Artificial intelliGence Registry record
Expected 2025-02-28; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06644339
2025-02
Study start Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06750341
2025-02
Study start Impact of CYP2C19 Genotype-guided Approach in Antiplatelet Therapy on Platelet Reactivity Index Among Coronary Artery Disease (CAD) Patients Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06759272
2025-02
Study start Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06785974
2025-02
Study start Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment Registry record
Expected 2025-02; that period ended on 2025-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06788626
2025-03-01
Study start Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits Registry record
Expected 2025-03-01; that period ended on 2025-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06115070
2025-03-01
2025-03-01
Primary completion Topical Nitro or Placebo Pre-Cath Registry record
Expected 2025-03-01; that period ended on 2025-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06289946
2025-03-01
Study start CAP-TEER: CerebrAl Protection During Transcatheter Edge-to-edge Repair Registry record
Expected 2025-03-01; that period ended on 2025-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06814210
2025-03-01
Study start Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD Registry record
Expected 2025-03-01; that period ended on 2025-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06820567
2025-03-01
Study start Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer Registry record
Expected 2025-03-01; that period ended on 2025-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06841965
2025-03-01
Study start Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months Registry record
Expected 2025-03-01; that period ended on 2025-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06841978
2025-03-01
2025-03-04
Study completion Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins Registry record
Expected 2025-03-04; that period ended on 2025-03-04.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06262685
2025-03-15
Primary completion Cerebroprotective Effect of Melatonin in Stroke Registry record
Expected 2025-03-15; that period ended on 2025-03-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05857046
2025-03-15
Primary completion Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients Registry record
Expected 2025-03-15; that period ended on 2025-03-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05957887
2025-03-15
2025-03-17
Study start Transcutaneous Laser Therapy in Chronic Kidney Disease Registry record
Expected 2025-03-17; that period ended on 2025-03-17.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06855992
2025-03-20
Primary completion Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY) Registry record
Expected 2025-03-20; that period ended on 2025-03-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06030544
2025-03-30
Primary completion Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features Registry record
Expected 2025-03-30; that period ended on 2025-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05131139
2025-03-30
Study completion Analysis of the Efficacy and Stability of a Wearable ECG Monitor Registry record
Expected 2025-03-30; that period ended on 2025-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06546046
2025-03
Study completion Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study Registry record
Expected 2025-03; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01627821
2025-03
Primary completion Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study Registry record
Expected 2025-03; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01627821
2025-03-31
Study completion Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) Registry record
Expected 2025-03-31; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02342444
2025-03-31
Study completion Safety and Efficacy Study of Abdominal Aortic Aneurysm Stent Graft System Registry record
Expected 2025-03-31; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT03687489
2025-03-31
Study completion Optimising Pacing for Contractility 2 Registry record
Expected 2025-03-31; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04201015
2025-03-31
Study completion Zinc, Chromium, Vitamin C, and Copper Combination Supplement for Prediabetes Progression Registry record
Expected 2025-03-31; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04511468
2025-03
Study completion Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER) Registry record
Expected 2025-03; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05164653
2025-03-31
Study completion Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation Registry record
Expected 2025-03-31; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05236348
2025-03-31
Primary completion Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation Registry record
Expected 2025-03-31; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05236348
2025-03-31
Study completion Reducing Edema After intraCerebral Hemorrhage Registry record
Expected 2025-03-31; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05263167
2025-03
Primary completion Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment Registry record
Expected 2025-03; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05327062
2025-03-31
Study completion The Effects of Allicor on Patients After Coronary Arteria Revascularization Treatment Registry record
Expected 2025-03-31; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05803759
2025-03-31
Study completion CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke Registry record
Expected 2025-03-31; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06078215
2025-03
Primary completion Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease Registry record
Expected 2025-03; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06203236
2025-03-31
Study completion Topical Nitro or Placebo Pre-Cath Registry record
Expected 2025-03-31; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06289946
2025-03
Primary completion BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Registry record
Expected 2025-03; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06322394
2025-03
Primary completion Role of Calcium Chloride Injection in Alleviating Atrial Fibrillation Post CABG Registry record
Expected 2025-03; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06378021
2025-03-31
Study completion BraiN20® Medical Device in Suspected Acute Stroke Patients Registry record
Expected 2025-03-31; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06421337
2025-03
Study start Epinephrine Versus Isoprenaline During Out-of-Hospital Cardiac Arrest With Asystole Registry record
Expected 2025-03; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06473116
2025-03
Study completion The Effect of Probiotics vs Activated Charcoal in the Management of CKD Patients Suffering From Uremic Pruritus. Registry record
Expected 2025-03; that period ended on 2025-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06579066